161 related articles for article (PubMed ID: 27718153)
1. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis.
Chen YP; Mao YP; Zhang WN; Chen L; Tang LL; Li WF; Liu X; Zhou GQ; Guo R; Sun Y; Kang TB; Zeng MS; Ma J
Oncotarget; 2016 Mar; 7(12):14973-82. PubMed ID: 26942870
[TBL] [Abstract][Full Text] [Related]
3. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
Zhou X; Zhu J; Zhou C; Wang W; Ding W; Chen M; Chen K; Li S; Chen X; Yang H
Radiat Oncol; 2023 Nov; 18(1):190. PubMed ID: 37974274
[TBL] [Abstract][Full Text] [Related]
4. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
[TBL] [Abstract][Full Text] [Related]
5. Individualized Concurrent Chemotherapy for Patients with Stage III-IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy.
Ji P; Lu Q; Chen X; Chen Y; Peng X; Chen Z; Lin C; Lin S; Zong J
Cancer Res Treat; 2023 Oct; 55(4):1113-1122. PubMed ID: 37170497
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy: A propensity score-matched analysis.
Li Y; Guan X; Xing X; Hu C
Head Neck; 2024 Jul; 46(7):1766-1776. PubMed ID: 38591178
[TBL] [Abstract][Full Text] [Related]
8. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study.
Zhang WW; Lin JY; Wang GY; Huang CL; Tang LL; Mao YP; Zhou GQ; Liu LZ; Tian L; Li JB; Ma J; Guo R
Radiother Oncol; 2024 May; 194():110189. PubMed ID: 38432309
[TBL] [Abstract][Full Text] [Related]
10. Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
Uchinami Y; Yasuda K; Minatogawa H; Dekura Y; Nishikawa N; Kinoshita R; Nishioka K; Katoh N; Mori T; Otsuka M; Miyamoto N; Suzuki R; Kobashi K; Shimizu Y; Taguchi J; Tsushima N; Kano S; Homma A; Aoyama H
Radiat Oncol J; 2024 Mar; 42(1):74-82. PubMed ID: 38549386
[TBL] [Abstract][Full Text] [Related]
11. Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy.
Li AC; Xiao WW; Shen GZ; Wang L; Xu AA; Cao YQ; Huang SM; Lin CG; Han F; Deng XW; Zhao C
Oncotarget; 2015 Sep; 6(27):24511-21. PubMed ID: 26087194
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Wang W; Feng M; Fan Z; Li J; Lang J
Biomed Res Int; 2014; 2014():814948. PubMed ID: 25162028
[TBL] [Abstract][Full Text] [Related]
13. Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.
Geretschläger A; Bojaxhiu B; Dal Pra A; Leiser D; Schmücking M; Arnold A; Ghadjar P; Aebersold DM
Radiat Oncol; 2015 Jan; 10():20. PubMed ID: 25595218
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy and intensity-modulated radiotherapy alone for stage II nasopharyngeal carcinoma.
Chen KH; Zhu XD; Li L; Qu S; Liang ZQ; Liang X; Pan XB; Liang ZG; Jiang YM
Oncotarget; 2016 Oct; 7(42):69041-69050. PubMed ID: 27634892
[TBL] [Abstract][Full Text] [Related]
15. Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients.
Peng H; Chen L; Tang LL; Zhang Y; Li WF; Mao YP; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
Oncotarget; 2016 Mar; 7(12):14963-72. PubMed ID: 26934649
[TBL] [Abstract][Full Text] [Related]
16. Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic area.
Lin ST; Meng DF; Yang Q; Wang W; Peng LX; Zheng LS; Qiang YY; Mei Y; Xu L; Li CZ; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Li HF; Huang BJ; Qian CN; Sun R
BMJ Open; 2020 Nov; 10(11):e037150. PubMed ID: 33172940
[TBL] [Abstract][Full Text] [Related]
17. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population.
Wang X; Huang N; Yip PL; Wang J; Huang R; Sun Z; Kang D; He Q; Deng X; Zhao C; Chua MLK; Han F
Radiother Oncol; 2024 May; 194():110154. PubMed ID: 38367938
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China.
Zang J; Li C; Zhao LN; Wang JH; Xu M; Luo SQ; Hitchcock YJ; Shi M
Medicine (Baltimore); 2016 May; 95(21):e3794. PubMed ID: 27227955
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study.
Wang F; Zhou L; Zhang LJ; Xie CB; Liao ZW; Lin XD; Wen YF
Radiother Oncol; 2024 Feb; 191():110081. PubMed ID: 38185256
[TBL] [Abstract][Full Text] [Related]
20. Matted Lymph Nodes on MRI in Nasopharyngeal Carcinoma: Prognostic Factor and Potential Indication for Induction Chemotherapy Benefits.
Dong A; Zhu S; Ma H; Wei X; Huang W; Ruan G; Liu L; Mo Y; Ai F
J Magn Reson Imaging; 2024 Jun; 59(6):1976-1990. PubMed ID: 37706438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
